Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS‐CMichael Camilleri, Jeffrey M. Johnston, Valerie Williams et al.|United European Gastroenterology Journal|2014Cited by 17
<p>Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary</p>Sheri Fehnel, Robyn T. Carson, Fred T. Fiedorek et al.|Clinical and Experimental Gastroenterology|2019Cited by 8
Development and Psychometric Evaluation of the Diabetic Gastroparesis Symptom Severity DiarySheri Fehnel, Fred T. Fiedorek, Lauren Nelson et al.|Gastroenterology|2017Cited by 6
Psychometric validation of patient-reported outcome measures assessing chronic constipationValerie Williams, Lauren Nelson, Sheri Fehnel et al.|Clinical and Experimental Gastroenterology|2014Cited by 4
Sa1094 Developing Benchmarks for Clinically Meaningful Change for IBS-C Symptoms Using Data From Two Phase 3 Trials of LinaclotideBrennan Spiegel, Jeffrey M. Johnston, Mark G. Currie et al.|Gastroenterology|2012Cited by 2